Integrating Pragmatic Comparative Effectiveness Research into a Tertiary Pain Management Center
将实用的比较有效性研究纳入三级疼痛管理中心
基本信息
- 批准号:10674005
- 负责人:
- 金额:$ 19.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:Academic TrainingAnticonvulsantsAntidepressive AgentsAnxietyCharacteristicsClinicClinic VisitsClinicalClinical DataClinical ResearchClinical TrialsClinical Trials DesignComparative Effectiveness ResearchDataData CollectionDecision MakingDecision Support SystemsDevelopmentEquipoiseExclusionFundingGoalsHealthcareHealthcare SystemsInstitutionJudgmentLearningLogistic RegressionsMachine LearningMaster of ScienceMedicalMedicineMental DepressionMentorsMentorshipModelingObservational StudyPainPain intensityPain interferencePain managementPatient CarePatientsPharmaceutical PreparationsPhysical FunctionPhysiciansPilot ProjectsPragmatic clinical trialPrecision HealthPredictive FactorProcessPublicationsRandomizedRandomized, Controlled TrialsReportingResearchResourcesScientistSiteSocial FunctioningSocietiesSurveysTestingTrainingUnited StatesUnited States National Institutes of Healthcareercareer developmentchronic painchronic pain managementchronic pain patientclinical careclinical epidemiologyclinical painclinical practiceclinical trainingcomorbiditycomparative effectiveness trialcompare effectivenesscosteffective therapyflexibilityimprovedindividual patientlow socioeconomic statusmachine learning algorithmopen sourcepain catastrophizingpatient orientedpatient subsetspersonalized medicinepoint of carepragmatic trialpredicting responsepredictive modelingpsychologicreal world applicationresearch and developmentresponsestatisticstooltreatment armtreatment response
项目摘要
Project Summary:
Chronic pain is a major healthcare problem with an annual cost of above $600 billion. The quality of data available
for treatments of chronic pain is not optimal. Generalizability of explanatory randomized controlled trial data is
problematic as these trials exclude up to 90% of patients: leaving out real-world patients with serious medical
and psychological comorbidities. Pragmatic trials embedded in patient care compare effectiveness of currently
used treatments in real-world application leading to findings that generalize to broader range of patients.
The changes in clinical practice and workflow necessary to integrate this type of research within patient care
present pragmatic challenges. In this research, my overall objective is to overcome these challenges using an
open-source learning health care system – CHOIR – developed by my mentor at the Stanford Pain Management
Center. CHOIR is currently used to track patients’ clinical trajectory and treatment response across multiple
academic sites resulting in over 25 publications characterizing chronic pain. Through our pilot studies, we have
already developed a point-of-care randomization for CHOIR that facilitates integration of research and patient
care by allowing the physicians to randomize patients during clinic visits. We have already demonstrated
feasibility of the randomization and data collection platform in two ongoing pilot pragmatic clinical trials.
We are proposing to better integrate pragmatic research within our clinical practice through conducting a
randomized comparative effectiveness trial in 450 patients with chronic pain comparing effectiveness of anti-
convulsants and anti-depressants (two most commonly used classes of medications for treatment of chronic
pain). We will use the data available in CHOIR as well as the real-world data generated from this clinical trial to
build, validate and test a model to predict what clinical characteristics can predict response to either of these
classes of medications.
The proposed study is the first step to use flexible point-of-care randomization to compare effectiveness of
different treatments in different subgroups of patients whenever equipoise exists. Our prediction model will guide
decision making process of clinicians choosing between these medications based on clinical characteristics of
individual patients.
Dr. Salmasi is a physician-scientist with clinical training in Pain Medicine as well as academic training in Clinical
Research and Epidemiology. The detailed career development and research plan presented in this application
will provide the required resources and mentorship for him to become an independent R01-funded expert in two
domains critical to his long-term career goals: (1) advanced clinical trial design and conduct; and (2) advanced
statistics and machine learning.
项目总结:
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A literature review of the impact of exclusion criteria on generalizability of clinical trial findings to patients with chronic pain.
- DOI:10.1097/pr9.0000000000001050
- 发表时间:2022-11
- 期刊:
- 影响因子:4.8
- 作者:
- 通讯作者:
Pragmatic Comparative Effectiveness Trials and Learning Health Systems in Pain Medicine: Opportunities and Challenges.
- DOI:10.1016/j.anclin.2023.03.010
- 发表时间:2023-06-01
- 期刊:
- 影响因子:0
- 作者:Salmasi, Vafi;Terkawi, Abdullah Sulieman;Mackey, Sean C
- 通讯作者:Mackey, Sean C
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vafi Salmasi其他文献
Vafi Salmasi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vafi Salmasi', 18)}}的其他基金
Integrating Pragmatic Comparative Effectiveness Research into a Tertiary Pain Management Center
将实用的比较有效性研究纳入三级疼痛管理中心
- 批准号:
10216024 - 财政年份:2021
- 资助金额:
$ 19.06万 - 项目类别:
Integrating Pragmatic Comparative Effectiveness Research into a Tertiary Pain Management Center
将实用的比较有效性研究纳入三级疼痛管理中心
- 批准号:
10398940 - 财政年份:2021
- 资助金额:
$ 19.06万 - 项目类别:
相似海外基金
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10004277 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10475298 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10013749 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10693904 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Study on how anticonvulsants affect car driving
抗惊厥药如何影响汽车驾驶的研究
- 批准号:
20K17977 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10266034 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10475109 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10248384 - 财政年份:2020
- 资助金额:
$ 19.06万 - 项目类别:
Prevention of neuropathic pain by antidepressants and anticonvulsants: in vivo patch-clamp analysis
抗抑郁药和抗惊厥药预防神经性疼痛:体内膜片钳分析
- 批准号:
24592355 - 财政年份:2012
- 资助金额:
$ 19.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
- 批准号:
8492175 - 财政年份:2009
- 资助金额:
$ 19.06万 - 项目类别:














{{item.name}}会员




